the mean (± SD) lag times (t,,,.) of diene formation were 111 ± 26 and 100 ± 27 mm, the peak rates of diene formation (Vm) were 5.99 ± 2.34 and 6.34 ± Smoking is one of the major risk factors for cardiovascular disease [1] . Cigarette smoking increases the concentrations of triglycerides and lowers the concentration of high-density Iipoprotein cholesterol (HDL-C) [2] [3] [4] [5] [6] [7] . These changes may contribute to the atherogenic potential of cigarette smoking.
Free radicals present in cigarette smoke promote the oxidation of proteins and lipids. For instance, the methionine residue at the reactive site of a1-antitrypsin is highly oxidized in smokers, which greatly decreases the protease inhibitor activity of a1-antitrypsin [8] . Evidence suggests that oxidatively modified low-density Ii 
Materials and Methods

SUBJECTS AND BLOOD COLLECTION
We studied 17 healthy smokers and 19 healthy nonsmokers (individuals who had never smoked). The participants were matched for body mass index, gender, and age (see Table I The kinetics of LDL oxidation was followed by determining the absorption of conjugated dienes at 234 nm as a function of time [19, 20] . The MDA content of LDL was estimated before (LDL-MDA) and after oxidation (LDL-MDA) according to Cheeseman et al. [21] as the concentration of TBARS. We used the following indices to describe the oxidizability of LDL:
(a) r'c,,,, the maximum rate of diene formation during the propagation phase; derived from the tangent to the absorbance (234 nln) vs time curve at its maximum slope by using #{128} = 29 500 L mol' cm to convert absorbance units into absolute diene concentrations.
(b) jnh, the lag time; the time interval between the zero time point (addition of Cu2) and the intersection of the extrapolated tangent to the absorbance and triglycerides, LDL-C, HDL-C, and apo B did not differ between smokers and nonsmokers.
Apo A-I was slightly lower in smokers than in nonsmokers, but the difference was of only borderline statistical significance (P = 0.066, onesided t-test). We analyzed the relationship between the indices of LDL oxidation, namely, diene lag time, peak rate of diene formation, amount of dienes generated during the propagation phase (di,,ax), LDL-MDA,,, and MDA produced during oxidation (LDL-MDA5) ( Table 3 and Fig. 1 ). We obtained statistically significant correlations between all indices studied, except that virtually no correlation existed between LDL-MDA5
and Vm or dii,ax ( Table 3) .
When we analyzed both genders together, LDL from smokers and nonsmokers contained almost equal amounts of MDA before oxidation (Table 4 and Fig. 1 ). We were not able to distinguish LDL from smokers and nonsmokers according to their oxidizabiliry in vitro, regardless whether we considered t,nh, "max' diiiax, or LDL-MDA5. Given that estrogens can affect the oxidizability of LDL [23, 24] , we examined men independently from women. Unexpectedly, this revealed that LDLwas significantly lower and t'nh was significantly higher in the male smokers than in the male nonsmokers.
We also were interested to see whether clinical or metabolic variables other than smoking habits were related to the propensity of LDL to oxidation. When nonsmokers and smokers were considered together, LDL-MDA8 significantly correlated 
. 
Discussion
The oxidation of LDL is considered a key event in the pathogenesis of atherosclerosis.
Cigarette smoke contains abundant amounts of oxidants and might hence promote oxidative modifications of LDL. Therefore, the purpose of this study was to compare the susceptibility to in vitro oxidation of LDL from smokers and nonsmokers.
The most surprising finding of this investigation was that LDL from smokers did not reveal enhanced susceptibility to in vitro oxidation compared with nonsmokers. This stands in contrast to the results of Scheffler et al. [14, 15] , but is partially consistent with data reported by Harats et al. [17] . [15] . We estimated that the power of our study to detect such a difference was -0.99 when a = values (LDL-MDA,,, and LDL-MDA6,,, respectively) in the current study were higher than those found by Harats et al. [17] , and this may reflect methodological differences. For instance, Harats et al. [17] determined TBARS by fluorescence (excitation at 515 nm, emission at 553 nm), whereas we read absorbances at 535 nm. We dialyzed the LDL in phosphate-buffered saline after ultracentrifugation, whereas Harats et al. [17] used Ham's FlO cell culture medium for this. Ham's FlO contains several constituents that can influence oxidation, e.g., vitamin E, vitamin C, cysteine, and Fe3. In our experience, this decreases the results of the assay for TBARS. Completely in line with this assumption is the fact that Scheffier et al. [14, 15] [12, 16, [25] [26] [27] [28] [29] , another indication that antioxidants had not been consumed at relevant amounts during isolation of the LDL.
One of the strengths of this study is that smokers and nonsmokers were stringently matched for potentially the most confounding factors, i.e., age and gender. Smokers and nonsmokers had similar lipoprotein concentrations, except for a tendency towards lower apo A-I concentrations in smokers, an observation consistent with earlier reports on the relationship of smoking habits and lipoproteins [7] . Although we did not determine the exposure to environmental tobacco smoke in the control group, it is unlikely that environmental tobacco smoke influenced our results. The composition of environmental smoke differs from that of mainstream smoke, being apparently more chemically inert and less biologically active, and the doses of environmental smoke are several orders of magnitude less than of mainstream smoke. Given that active smoking of <10 cigarettes per day does not increase the risk of coronary artery disease [30] , it is to hard to conceive that exposure of nonsmokers to environmental tobacco smoke would exert any effects on the oxidizability of LDL. The group of smokers included individuals who had been exposed to huge amounts of oxidants for decades. Despite this, they did not suffer from cardiovascular or pulmonary disease. We hence hypothesize that these individuals must have successfully withstood the sustained oxidative challenges by virtue of a favorable combination of protective factors-which may also account for the "normal" susceptibility of the smokers' LDL to oxidation.
Such a selection bias may also account for the paradoxical finding that LDL from the male smokers were significantly more resistant to oxidation than LDL from the male nonsmokers. Consistent with our findings, in the studies claiming differences in LDL oxidizability, both the smokers and the nonsmokers were younger than in our study: Scheffler et al. [14, 15] [ 16, 20, 28] and indeed suggest that still other factors govern LDL oxidation.
In the present study we demonstrated that LDL-MDA5, the normalized amount of MDA produced during the oxidation of LDL, was positively correlated with age, body mass index, and the plasma concentrations of triglycerides and LDL. These findings confirm that LDL from individuals with hyperlipidemia are more prone to oxidative modification [31] , but stand in contrast to a recent report suggesting that aging does not increase the oxidizability of LDL [32] . Apart from the aforementioned factors, the lipid and fatty acid composition of LDL, together with structural or conformational variations of apo B, will probably affect LDL oxidizability. Tribble et al. [33] showed that small, dense LDL subfractions are more readily oxidized than large, buoyant LDL; in the present study, d,,,ax, the amount of dienes produced during the propagation phase, was positively correlated with the apo B/LDL-C ratio, which reflects the relative abundance of small, dense LDL. Apo B itself may also be intimately involved in the process of LDL oxidation. The specific binding sites on apo B for Cu2 ions may provide centers for repeated free radical production [34] . Genetic variation of apo B may alter the number and affinity of these binding sites and thus affect the susceptibility of LDL to oxidation. Our finding of essentially normal LDL oxidizability in smokers who remained healthy up to an average age of 52 years may thus support the existence of some genetic or metabolic condition that protects LDL from oxidative damage by cigarette smoking.
Yet another factor may explain why LDL from smokers and nonsmokers were equally sensitive to oxidation. Frei et al. [35] reported that in vitro exposure of blood plasma to the gas phase of cigarette smoke did not induce lipid peroxidation until the endogenous ascorbic acid had been completely oxidized; in contrast, a-tocopherol was not consumed at a significant rate in those studies. Consistently, exposure to cigarette smoke caused oxidation of plasma protein thiols and albumin-bound bilirubin, but modifications of LDL that would increase their electrophoretic mobility were slight, and no apparent degradation of apo B was observed. This suggests that cigarette smoking might deplete hydrophilic antioxidants much earlier than lipophilic ones and that plasma proteins other than lipoproteins are the primary targets for the oxidants in cigarette smoke.
In conclusion, using two independent methods, we obtained no evidence that LDL from healthy smokers was more prone to in vitro oxidative modification than LDL from healthy nonsmokers. This finding is in conflict with previous reports [14, 15, 17] that suggested an increased sensitivity of LDL from smokers. Further work is, therefore, required to settle this controversy and to determine more precisely the influence of cigarette smoking on the oxidizability of LDL. 
